Amarin Corporation plc - American Depositary Receipt logo

Amarin Corporation plc - American Depositary Receipt (AMRN)

Market Closed
3 Jun, 20:00
NASDAQ (CM) NASDAQ (CM)
$
14. 53
+0.06
+0.41%
$
300.31M Market Cap
- P/E Ratio
- Div Yield
50,729 Volume
- Eps
$ 14.47
Previous Close
Investors:
Add Transaction
Day Range
14.2 14.78
Year Range
11.65 20.9
Want to track AMRN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Amarin (AMRN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Amarin (AMRN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

After losing some value lately, a hammer chart pattern has been formed for Amarin (AMRN), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

Zacks | 9 months ago
Is Amarin (AMRN) Outperforming Other Medical Stocks This Year?

Is Amarin (AMRN) Outperforming Other Medical Stocks This Year?

Here is how Amarin (AMRN) and Bayer Aktiengesellschaft (BAYRY) have performed compared to their sector so far this year.

Zacks | 10 months ago
Amarin Corporation plc (AMRN) Q2 2025 Earnings Call Transcript

Amarin Corporation plc (AMRN) Q2 2025 Earnings Call Transcript

Amarin Corporation plc (NASDAQ:AMRN ) Q2 2025 Earnings Conference Call July 30, 2025 8:00 AM ET Company Participants Aaron D. Berg - CEO, President & Director Mark Marmur - Corporate Participant Peter L.

Seekingalpha | 10 months ago
Amarin Gears Up to Report Q2 Earnings: Here's What to Expect

Amarin Gears Up to Report Q2 Earnings: Here's What to Expect

AMRN braces up for second-quarter results as U.S. Vascepa sales are likely to slide, while growth in the EU looks imminent.

Zacks | 10 months ago
3 Strong Buy Breakout Stocks for Explosive Returns

3 Strong Buy Breakout Stocks for Explosive Returns

MAMA, BSET and AMRN meet breakout criteria with strong earnings growth and prices near 52-week highs.

Zacks | 10 months ago
Take the Zacks Approach to Beat the Markets: Amarin, Mogo, 3M in Focus

Take the Zacks Approach to Beat the Markets: Amarin, Mogo, 3M in Focus

Zacks' model upgrades drove major gains for Amarin, Mogo and 3M, even as broader markets wobbled on tariff fears.

Zacks | 10 months ago
Are Medical Stocks Lagging Amarin (AMRN) This Year?

Are Medical Stocks Lagging Amarin (AMRN) This Year?

Here is how Amarin (AMRN) and Abbott (ABT) have performed compared to their sector so far this year.

Zacks | 11 months ago
Best Momentum Stock to Buy for June 27th

Best Momentum Stock to Buy for June 27th

GTX, LPG and AMRN made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 27, 2025.

Zacks | 11 months ago
Amarin Soars 27% on Vazkepa Licensing Deal With Recordati in the EU

Amarin Soars 27% on Vazkepa Licensing Deal With Recordati in the EU

AMRN jumps 27% after inking an exclusive EU licensing deal with Recordati to expand Vazkepa's reach and cut costs.

Zacks | 11 months ago
Amarin (AMRN) Soars 27.3%: Is Further Upside Left in the Stock?

Amarin (AMRN) Soars 27.3%: Is Further Upside Left in the Stock?

Amarin (AMRN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Zacks | 11 months ago
Amarin (AMRN) Now Trades Above Golden Cross: Time to Buy?

Amarin (AMRN) Now Trades Above Golden Cross: Time to Buy?

From a technical perspective, Amarin Corporation PLC (AMRN) is looking like an interesting pick, as it just reached a key level of support. AMRN's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world.

Zacks | 11 months ago
Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?

Here is how Amarin (AMRN) and GSK (GSK) have performed compared to their sector so far this year.

Zacks | 11 months ago
Loading...
Load More